NOVOBODIES
Live / Applied — Second extension granted (statement of use) (as of 05 Dec 2025)
What this means for you
Not registered yet, but its 22 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98370053
- Mark type
- Stylized text
- Filed
- 22 Jan 2024
- Published for opposition
- 24 Sept 2024
- Attorney of record
- Lori Tonnes
Goods and services
- Class 005 — Pharmaceuticals: Target binding proteins and reagents for medical, diagnostic, clinical, and therapeutic use
Owner
- Monod Bio, Inc., Seattle, WA, US
- Monod Bio, Inc., Seattle, WA, US
Prosecution history
- 06 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Dec 2025 — SOU EXTENSION 2 GRANTED
- 12 Nov 2025 — SOU EXTENSION 2 FILED
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2025 — CORRECTED NOA E-MAILED
- 08 Oct 2025 — SOU EXTENSION 1 GRANTED
- 14 Apr 2025 — SOU EXTENSION 1 FILED
- 08 Oct 2025 — DIVISIONAL PROCESSING COMPLETE
- 15 Apr 2025 — DIVISIONAL REQUEST RECEIVED
- 08 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Apr 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 15 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED